Presentation Details
| Managing medical challenges of gene therapy Stacy Croteau. |
Abstract
Integration of commercial gene therapy into routine clinical care is complex. This presentation will explore peri-infusion clinical considerations and practices for the currently licensed hemophilia A and B gene therapy products.
No part of this publication may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the author.